Liver Cancer Diagnostics Market
Liver Cancer Diagnostics Market - Global Industry Assessment & Forecast
#
Pages:
149
Base Year:
2023
Jun - 2024
Format:
Report Code:
VMR-2527
Segments Covered
By
Test Type Laboratory Tests, Imaging, Endoscopy, Biopsy, Other Test Types
-
By
End Use Hospitals & Diagnostic Laboratories, Academic & Research Institutes, Pharmaceutical & CRO Laboratories
-
By
Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
 Base Year:
|
2023 |
| Forecast
Years:
|
2024 - 2032 |
 Historical
Years:
|
2018 - 2022 |
 Revenue
2023: |
USD 10.17 Billion |
 Revenue 2032:
|
USD 19.31 Billion |
 Revenue CAGR
(2024 - 2032): |
7.38% |
Fastest Growing Region (2024 -
2032)
|
Asia Pacific |
Largest Region (2023):
|
North America |
Customization Offered
Cross-segment Market Size and
Analysis
for Mentioned Segments- Additional Company Profiles (Upto 5
With
No Cost)
- Additional Countries (Apart From
Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request
Customization Speak To
Analyst
Liver Cancer Diagnostics Market Segment Analysis
- Liver Cancer Diagnostics Test Type Outlook (Revenue, USD Million, 2018 - 2030)
- Laboratory Tests
- Imaging
- Endoscopy
- Biopsy
- Other Test Types
- Liver Cancer Diagnostics End Use Outlook (Revenue, USD Million, 2018 - 2030)
- Hospitals & Diagnostic Laboratories
- Academic & Research Institutes
- Pharmaceutical & CRO Laboratories
-
Regional Outlook (Revenue, USD Billion/Million, 2018 - 2030)
- North America
-
North America Liver Cancer Diagnostics Market, by Test Type
- Laboratory Tests
- Imaging
- Endoscopy
- Biopsy
- Other Test Types
-
North America Liver Cancer Diagnostics Market, by End Use
- Hospitals & Diagnostic Laboratories
- Academic & Research Institutes
- Pharmaceutical & CRO Laboratories
- U.S.
- U.S. Liver Cancer Diagnostics Market, by Test Type
- Laboratory Tests
- Imaging
- Endoscopy
- Biopsy
- Other Test Types
- U.S. Liver Cancer Diagnostics Market, by End Use
- Hospitals & Diagnostic Laboratories
- Academic & Research Institutes
- Pharmaceutical & CRO Laboratories
- U.S. Liver Cancer Diagnostics Market, by Test Type
- Canada
- Canada Liver Cancer Diagnostics Market, by Test Type
- Laboratory Tests
- Imaging
- Endoscopy
- Biopsy
- Other Test Types
- Canada Liver Cancer Diagnostics Market, by End Use
- Hospitals & Diagnostic Laboratories
- Academic & Research Institutes
- Pharmaceutical & CRO Laboratories
- Canada Liver Cancer Diagnostics Market, by Test Type
-
Mexico
- Mexico Liver Cancer Diagnostics Market, by Test Type
- Laboratory Tests
- Imaging
- Endoscopy
- Biopsy
- Other Test Types
- Mexico Liver Cancer Diagnostics Market, by End Use
- Hospitals & Diagnostic Laboratories
- Academic & Research Institutes
- Pharmaceutical & CRO Laboratories
- Mexico Liver Cancer Diagnostics Market, by Test Type
-
North America Liver Cancer Diagnostics Market, by Test Type
- Europe
-
Europe Liver Cancer Diagnostics Market, by Test Type
- Laboratory Tests
- Imaging
- Endoscopy
- Biopsy
- Other Test Types
-
Europe Liver Cancer Diagnostics Market, by End Use
- Hospitals & Diagnostic Laboratories
- Academic & Research Institutes
- Pharmaceutical & CRO Laboratories
- U. K.
- U.K. Liver Cancer Diagnostics Market, by Test Type
- Laboratory Tests
- Imaging
- Endoscopy
- Biopsy
- Other Test Types
- U.K. Liver Cancer Diagnostics Market, by End Use
- Hospitals & Diagnostic Laboratories
- Academic & Research Institutes
- Pharmaceutical & CRO Laboratories
- U.K. Liver Cancer Diagnostics Market, by Test Type
- France
- France Liver Cancer Diagnostics Market, by Test Type
- Laboratory Tests
- Imaging
- Endoscopy
- Biopsy
- Other Test Types
- France Liver Cancer Diagnostics Market, by End Use
- Hospitals & Diagnostic Laboratories
- Academic & Research Institutes
- Pharmaceutical & CRO Laboratories
- France Liver Cancer Diagnostics Market, by Test Type
-
Germany
- Germany Liver Cancer Diagnostics Market, by Test Type
- Laboratory Tests
- Imaging
- Endoscopy
- Biopsy
- Other Test Types
- Germany Liver Cancer Diagnostics Market, by End Use
- Hospitals & Diagnostic Laboratories
- Academic & Research Institutes
- Pharmaceutical & CRO Laboratories
- Germany Liver Cancer Diagnostics Market, by Test Type
-
Italy
- Italy Liver Cancer Diagnostics Market, by Test Type
- Laboratory Tests
- Imaging
- Endoscopy
- Biopsy
- Other Test Types
- Italy Liver Cancer Diagnostics Market, by End Use
- Hospitals & Diagnostic Laboratories
- Academic & Research Institutes
- Pharmaceutical & CRO Laboratories
- Italy Liver Cancer Diagnostics Market, by Test Type
-
Spain
- Spain Liver Cancer Diagnostics Market, by Test Type
- Laboratory Tests
- Imaging
- Endoscopy
- Biopsy
- Other Test Types
- Spain Liver Cancer Diagnostics Market, by End Use
- Hospitals & Diagnostic Laboratories
- Academic & Research Institutes
- Pharmaceutical & CRO Laboratories
- Spain Liver Cancer Diagnostics Market, by Test Type
-
Rest of Europe
- Rest of Europe Liver Cancer Diagnostics Market, by Test Type
- Laboratory Tests
- Imaging
- Endoscopy
- Biopsy
- Other Test Types
- Rest of Europe Liver Cancer Diagnostics Market, by End Use
- Hospitals & Diagnostic Laboratories
- Academic & Research Institutes
- Pharmaceutical & CRO Laboratories
- Rest of Europe Liver Cancer Diagnostics Market, by Test Type
-
Europe Liver Cancer Diagnostics Market, by Test Type
- Asia Pacific
-
Asia Pacific Liver Cancer Diagnostics Market, by Test Type
- Laboratory Tests
- Imaging
- Endoscopy
- Biopsy
- Other Test Types
-
Asia Pacific Liver Cancer Diagnostics Market, by End Use
- Hospitals & Diagnostic Laboratories
- Academic & Research Institutes
- Pharmaceutical & CRO Laboratories
- China
- China Liver Cancer Diagnostics Market, by Test Type
- Laboratory Tests
- Imaging
- Endoscopy
- Biopsy
- Other Test Types
- China Liver Cancer Diagnostics Market, by End Use
- Hospitals & Diagnostic Laboratories
- Academic & Research Institutes
- Pharmaceutical & CRO Laboratories
- China Liver Cancer Diagnostics Market, by Test Type
- Japan
- Japan Liver Cancer Diagnostics Market, by Test Type
- Laboratory Tests
- Imaging
- Endoscopy
- Biopsy
- Other Test Types
- Japan Liver Cancer Diagnostics Market, by End Use
- Hospitals & Diagnostic Laboratories
- Academic & Research Institutes
- Pharmaceutical & CRO Laboratories
- Japan Liver Cancer Diagnostics Market, by Test Type
-
Germany
- Germany Liver Cancer Diagnostics Market, by Test Type
- Laboratory Tests
- Imaging
- Endoscopy
- Biopsy
- Other Test Types
- Germany Liver Cancer Diagnostics Market, by End Use
- Hospitals & Diagnostic Laboratories
- Academic & Research Institutes
- Pharmaceutical & CRO Laboratories
- Germany Liver Cancer Diagnostics Market, by Test Type
-
India
- India Liver Cancer Diagnostics Market, by Test Type
- Laboratory Tests
- Imaging
- Endoscopy
- Biopsy
- Other Test Types
- India Liver Cancer Diagnostics Market, by End Use
- Hospitals & Diagnostic Laboratories
- Academic & Research Institutes
- Pharmaceutical & CRO Laboratories
- India Liver Cancer Diagnostics Market, by Test Type
-
South Korea
- South Korea Liver Cancer Diagnostics Market, by Test Type
- Laboratory Tests
- Imaging
- Endoscopy
- Biopsy
- Other Test Types
- South Korea Liver Cancer Diagnostics Market, by End Use
- Hospitals & Diagnostic Laboratories
- Academic & Research Institutes
- Pharmaceutical & CRO Laboratories
- South Korea Liver Cancer Diagnostics Market, by Test Type
-
South East Asia
- South East Asia Liver Cancer Diagnostics Market, by Test Type
- Laboratory Tests
- Imaging
- Endoscopy
- Biopsy
- Other Test Types
- South East Asia Liver Cancer Diagnostics Market, by End Use
- Hospitals & Diagnostic Laboratories
- Academic & Research Institutes
- Pharmaceutical & CRO Laboratories
- South East Asia Liver Cancer Diagnostics Market, by Test Type
-
Rest of Asia Pacific
- Rest of Asia Pacific Liver Cancer Diagnostics Market, by Test Type
- Laboratory Tests
- Imaging
- Endoscopy
- Biopsy
- Other Test Types
- Rest of Asia Pacific Liver Cancer Diagnostics Market, by End Use
- Hospitals & Diagnostic Laboratories
- Academic & Research Institutes
- Pharmaceutical & CRO Laboratories
- Rest of Asia Pacific Liver Cancer Diagnostics Market, by Test Type
-
Asia Pacific Liver Cancer Diagnostics Market, by Test Type
- Latin America
-
Latin America Liver Cancer Diagnostics Market, by Test Type
- Laboratory Tests
- Imaging
- Endoscopy
- Biopsy
- Other Test Types
-
Latin America Liver Cancer Diagnostics Market, by End Use
- Hospitals & Diagnostic Laboratories
- Academic & Research Institutes
- Pharmaceutical & CRO Laboratories
- Brazil
- Brazil Liver Cancer Diagnostics Market, by Test Type
- Laboratory Tests
- Imaging
- Endoscopy
- Biopsy
- Other Test Types
- Brazil Liver Cancer Diagnostics Market, by End Use
- Hospitals & Diagnostic Laboratories
- Academic & Research Institutes
- Pharmaceutical & CRO Laboratories
- Brazil Liver Cancer Diagnostics Market, by Test Type
- Argentina
- Argentina Liver Cancer Diagnostics Market, by Test Type
- Laboratory Tests
- Imaging
- Endoscopy
- Biopsy
- Other Test Types
- Argentina Liver Cancer Diagnostics Market, by End Use
- Hospitals & Diagnostic Laboratories
- Academic & Research Institutes
- Pharmaceutical & CRO Laboratories
- Argentina Liver Cancer Diagnostics Market, by Test Type
-
Rest of Latin America
- Rest of Latin America Liver Cancer Diagnostics Market, by Test Type
- Laboratory Tests
- Imaging
- Endoscopy
- Biopsy
- Other Test Types
- Rest of Latin America Liver Cancer Diagnostics Market, by End Use
- Hospitals & Diagnostic Laboratories
- Academic & Research Institutes
- Pharmaceutical & CRO Laboratories
- Rest of Latin America Liver Cancer Diagnostics Market, by Test Type
-
Latin America Liver Cancer Diagnostics Market, by Test Type
- Middle East & Africa
-
Middle East & Africa Liver Cancer Diagnostics Market, by Test Type
- Laboratory Tests
- Imaging
- Endoscopy
- Biopsy
- Other Test Types
-
Middle East & Africa Liver Cancer Diagnostics Market, by End Use
- Hospitals & Diagnostic Laboratories
- Academic & Research Institutes
- Pharmaceutical & CRO Laboratories
- GCC Countries
- GCC Countries Liver Cancer Diagnostics Market, by Test Type
- Laboratory Tests
- Imaging
- Endoscopy
- Biopsy
- Other Test Types
- GCC Countries Liver Cancer Diagnostics Market, by End Use
- Hospitals & Diagnostic Laboratories
- Academic & Research Institutes
- Pharmaceutical & CRO Laboratories
- GCC Countries Liver Cancer Diagnostics Market, by Test Type
- South Africa
- South Africa Liver Cancer Diagnostics Market, by Test Type
- Laboratory Tests
- Imaging
- Endoscopy
- Biopsy
- Other Test Types
- South Africa Liver Cancer Diagnostics Market, by End Use
- Hospitals & Diagnostic Laboratories
- Academic & Research Institutes
- Pharmaceutical & CRO Laboratories
- South Africa Liver Cancer Diagnostics Market, by Test Type
-
Rest of Middle East & Africa
- Rest of Middle East & Africa Liver Cancer Diagnostics Market, by Test Type
- Laboratory Tests
- Imaging
- Endoscopy
- Biopsy
- Other Test Types
- Rest of Middle East & Africa Liver Cancer Diagnostics Market, by End Use
- Hospitals & Diagnostic Laboratories
- Academic & Research Institutes
- Pharmaceutical & CRO Laboratories
- Rest of Middle East & Africa Liver Cancer Diagnostics Market, by Test Type
-
Middle East & Africa Liver Cancer Diagnostics Market, by Test Type
- North America
Vantage Market
Research | 03-Jul-2024
FAQ
Frequently Asked Question
What is the global demand for Liver Cancer Diagnostics in terms of revenue?
-
The global Liver Cancer Diagnostics valued at USD 10.17 Billion in 2023 and is expected to reach USD 19.31 Billion in 2032 growing at a CAGR of 7.38%.
Which are the prominent players in the market?
-
The prominent players in the market are Abbott Laboratories (U.S.), Thermo Fisher Scientific Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Qiagen N.V. (Germany), Siemens Healthineers (Germany), Becton Dickinson & Company (U.S.), Illumina Inc. (U.S.), Epigenomics AG (Germany), Koninklijke Philips N.V. (Netherlands), Fujifilm Medical Systems U.S.A. Inc. (U.S.).
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 7.38% between 2024 and 2032.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Liver Cancer Diagnostics include
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Liver Cancer Diagnostics in 2023.
